Tenax Therapeutics (TENX) Cash & Current Investments (2016 - 2017)
Historic Cash & Current Investments for Tenax Therapeutics (TENX) over the last 8 years, with Q3 2017 value amounting to $8.5 million.
- Tenax Therapeutics' Cash & Current Investments rose 1412.52% to $8.5 million in Q3 2017 from the same period last year, while for Sep 2017 it was $8.5 million, marking a year-over-year increase of 1412.52%. This contributed to the annual value of $13.3 million for FY2016, which is N/A changed from last year.
- Tenax Therapeutics' Cash & Current Investments amounted to $8.5 million in Q3 2017, which was up 1412.52% from $8.8 million recorded in Q2 2017.
- Tenax Therapeutics' Cash & Current Investments' 5-year high stood at $58.3 million during Q2 2014, with a 5-year trough of $783528.0 in Q2 2013.
- Over the past 5 years, Tenax Therapeutics' median Cash & Current Investments value was $8.7 million (recorded in 2017), while the average stood at $12.7 million.
- Per our database at Business Quant, Tenax Therapeutics' Cash & Current Investments skyrocketed by 734332.75% in 2014 and then plummeted by 8640.88% in 2015.
- Tenax Therapeutics' Cash & Current Investments (Quarter) stood at $783528.0 in 2013, then surged by 7343.33% to $58.3 million in 2014, then plummeted by 65.38% to $20.2 million in 2015, then tumbled by 34.22% to $13.3 million in 2016, then tumbled by 35.74% to $8.5 million in 2017.
- Its last three reported values are $8.5 million in Q3 2017, $8.8 million for Q2 2017, and $12.5 million during Q1 2017.